IRIS
CENCINI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.743
EU - Europa 3.219
AS - Asia 1.719
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 180
AF - Africa 92
OC - Oceania 4
Totale 9.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.683
RU - Federazione Russa 732
GB - Regno Unito 670
IT - Italia 625
CN - Cina 522
SG - Singapore 503
IE - Irlanda 374
BR - Brasile 261
SE - Svezia 201
VN - Vietnam 188
FR - Francia 143
BD - Bangladesh 135
UA - Ucraina 128
HK - Hong Kong 123
DE - Germania 115
FI - Finlandia 105
KR - Corea 54
IN - India 53
ZA - Sudafrica 40
TR - Turchia 32
CA - Canada 31
AR - Argentina 25
JP - Giappone 21
PL - Polonia 21
NL - Olanda 20
IQ - Iraq 19
MX - Messico 18
AT - Austria 16
BE - Belgio 15
KE - Kenya 14
CZ - Repubblica Ceca 12
NG - Nigeria 11
SA - Arabia Saudita 11
ES - Italia 10
PK - Pakistan 8
CI - Costa d'Avorio 7
CO - Colombia 7
IR - Iran 7
EC - Ecuador 6
MA - Marocco 6
SK - Slovacchia (Repubblica Slovacca) 6
UZ - Uzbekistan 6
EG - Egitto 5
PH - Filippine 5
TN - Tunisia 5
AU - Australia 4
ID - Indonesia 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
JO - Giordania 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
BG - Bulgaria 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 9.090
Salva come PNG Salva come JPEG
Città #
Southend 594
Fairfield 389
Dublin 372
Dallas 343
Singapore 314
Ashburn 302
Moscow 216
Santa Clara 200
Milan 188
Chandler 170
Woodbridge 170
San Jose 164
Houston 150
Beijing 147
Seattle 140
Ann Arbor 135
Wilmington 129
Cambridge 120
Hong Kong 118
Jacksonville 107
Council Bluffs 104
Hefei 97
Siena 77
Princeton 63
Dearborn 60
The Dalles 60
Los Angeles 59
Rome 57
Seoul 54
Ho Chi Minh City 50
Hanoi 48
Lauterbourg 47
Nanjing 44
New York 44
Munich 42
Johannesburg 37
Helsinki 35
Turku 32
Izmir 28
Lappeenranta 27
Menlo Park 25
Florence 24
Boardman 22
San Mateo 22
São Paulo 22
Orem 21
Buffalo 20
Columbus 20
Chicago 19
Redondo Beach 18
Figino 17
Dong Ket 16
Brussels 14
London 14
Chennai 13
Bengaluru 12
Bologna 11
Frankfurt am Main 11
Guangzhou 11
Nanchang 11
San Diego 11
Tianjin 11
Warsaw 11
Brooklyn 10
Haiphong 10
Jinan 10
San Francisco 10
Shanghai 10
Toronto 10
Atlanta 9
Da Nang 9
Denver 9
Kunming 9
Montreal 9
Nairobi 9
Rio de Janeiro 9
Shenyang 9
Tokyo 9
Turin 9
Vienna 9
Abuja 8
Baghdad 8
Belo Horizonte 8
Abidjan 7
Boston 7
Changsha 7
Naples 7
Portsmouth 7
Stockholm 7
Brno 6
Hebei 6
Jiaxing 6
Mexico City 6
Phoenix 6
Poplar 6
Amsterdam 5
Genoa 5
Maceió 5
Memphis 5
New Delhi 5
Totale 6.195
Salva come PNG Salva come JPEG
Nome #
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 451
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 308
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 283
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 259
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma 248
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large B-cell lymphoma 245
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 239
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab 229
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 226
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 225
New perspectives for patients with primary CNS lymphoma 224
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 224
Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma 219
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma 219
Impressive and durable response in a case of multiple relapsed mantle cell lymphoma treated with bortezomib and rituximab 215
Primary Nasopharyngeal Hodgkin Lymphoma 211
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant 204
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas 203
Prognostic significance of lymphocyte/monocyte count and neutrophil/lymphocyte count in peripheral T cell lymphoma 201
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience 198
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma 195
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 194
Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma 193
Therapeutic use of Brentuximab Vedotin In Cd30+ hematologic malignancies 191
Long term remission in a case of Plasmablastic lymphoma treated with COMP (Cyclophosphamide, Liposomal Doxorubicin, Vincristine, Prednisone) and Bortezomib 191
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma 191
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review 188
Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma 184
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 182
Prognostic role of m2 Tumour-Associated macrophages in lymphoproliferative disorders 181
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 162
Development and implementation of the International AIDA Network Castleman’s disease registry 158
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma 154
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 151
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 148
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 146
How to manage early-stage follicular lymphoma 142
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications 142
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi 139
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? 139
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series 138
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma 135
Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract 128
Survival outcomes of patients with mantle cell lymphoma: a retrospective, 15-Year, real-life study 118
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) 110
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 106
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 96
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi 91
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone 76
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network) 70
Totale 9.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.135
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022447 0 47 34 47 31 27 15 15 24 48 54 105
2022/2023636 34 62 85 73 77 130 17 43 63 6 24 22
2023/2024578 20 15 35 58 14 125 220 10 8 32 3 38
2024/20251.278 45 71 169 50 157 73 20 65 59 85 155 329
2025/20263.381 242 384 291 446 680 128 331 90 91 147 123 428
2026/2027277 165 112 0 0 0 0 0 0 0 0 0 0
Totale 9.270